CIMIT ModelClinical ImpactCommunity: CoLabContact Us
search
High Throughput Development of Biomaterials for Stem Cell Engineering


7.6.2010

SPEAKER:
Ying Mei, PhD, Postdoctoral Associate, Laboratory of Institute Professor Robert Langer, Massachusetts Institute of Technology

MODERATOR:
Frederick Schoen, MD, PHD, Executive Vice Chairman, Department of Pathology, Brigham and Women's Hospital; Professor of Pathology and Health Sciences and Technology (HST), Harvard Medical School; CIMIT Site Miner, Brigham and Women’s Hospital

Video not available at this time.

 


Forum Abstract

The importance of materials has been increasingly recognized in a wide range of biomedical applications including drug delivery, tissue engineering and stem cell engineering. Due to the complexity of biological systems, it can be challenging to rapidly identify materials with desirable biological properties using conventional low throughput, iterative design approach.  On the other hand, high throughput approaches could offer several advantages, including decreased cost and the increased possibility of discovering new materials with desirable properties. Dr. Mei will describe recent work in developing high throughput approaches for rapid nanoliter scale synthesis of thousands of biomaterials. The high throughput testing of their chemical, material, and biological properties will also be described. This technology has been shown to accelerate the discovery of materials that can direct a variety of stem cell behaviors.

Post a Comment



Integrated Clinical EnvironmentsNeuroHealth, PTSD & TBI Industry I Foundation Engagement Homebase & Warfighter CareAccelerator

CIMIT does not rate, endorse, recommend or prescribe any products, procedures or services. Subscribe to CIMIT News in RSS

Contact the Webmaster Site Acknowledgements Copyright © 2011 CIMIT. All rights reserved. site map linking policy privacy